BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lymphocyte, Laryngoscope, Tamoxifen, rs2230926, SLC12A1, Coagulation, Allergy to pollen)
Bookmark Forward

QuickView for prostacyclin (compound)


Genetic Markers

Most Correlated Genes

  1. P2RY12
  2. CCL23
  3. CCL22
  4. DMBT1
  5. GPRC5C
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN
  2. response to stress
  3. GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP
  4. FISCHER_DREAM_TARGETS
  5. FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Leukemic pre-B cells treated with different retinoids in combination with IKZF1-IK6 overexpression
  2. Drug target sets for approved compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Effect of epoprostenol-induced thrombocytopaenia on lung transplantation for pulmonary arterial hype…
  2. Dietary fatty acids and flight-training influence the expression of the eicosanoid hormone prostacyc…
  3. Successful epoprostenol withdrawal and termination with an aid of the exercise stress test in pulmon…
  4. Roles of endothelial prostaglandin I2 in maintaining synchronous spontaneous Ca2+ transients in rect…
  5. Comparison of 2 different inhaled epoprostenol dosing strategies for acute respiratory distress synd…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist
  2. Prostacyclin's Effect on Platelet Responsiveness
  3. Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
  4. Platelet Reactivity and Treatment With Prostacyclin Analogues in Pulmonary Arterial Hypertension
  5. Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.